| Literature DB >> 26341739 |
Rashi Singhal1, Gowtham K Annarapu1, Ankita Pandey2, Sheetal Chawla2, Amrita Ojha2, Avinash Gupta2, Miguel A Cruz3, Tulika Seth4, Prasenjit Guchhait5.
Abstract
Intravascular hemolysis increases the risk of hypercoagulation and thrombosis in hemolytic disorders. Our study shows a novel mechanism by which extracellular hemoglobin directly affects platelet activation. The binding of Hb to glycoprotein1bα activates platelets. Lower concentrations of Hb (0.37-3 μM) significantly increase the phosphorylation of signaling adapter proteins, such as Lyn, PI3K, AKT, and ERK, and promote platelet aggregation in vitro. Higher concentrations of Hb (3-6 μM) activate the pro-apoptotic proteins Bak, Bax, cytochrome c, caspase-9 and caspase-3, and increase platelet clot formation. Increased plasma Hb activates platelets and promotes their apoptosis, and plays a crucial role in the pathogenesis of aggregation and development of the procoagulant state in hemolytic disorders. Furthermore, we show that in patients with paroxysmal nocturnal hemoglobinuria, a chronic hemolytic disease characterized by recurrent events of intravascular thrombosis and thromboembolism, it is the elevated plasma Hb or platelet surface bound Hb that positively correlates with platelet activation. Copyright© Ferrata Storti Foundation.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26341739 PMCID: PMC4666328 DOI: 10.3324/haematol.2015.132183
Source DB: PubMed Journal: Haematologica ISSN: 0390-6078 Impact factor: 9.941